Hainan Zhuoke Pharmaceutical

Hainan Zhuoke Pharmaceutical is a wholly-owned subsidiary of Hainan Poly Pharm (Puli Pharmaceutical), a prominent Chinese pharmaceutical company specializing in high-end generic drugs and contrast agents. Based in the Haikou National High-tech Zone, Hainan Zhuoke serves as a critical manufacturing and R&D hub for the group's international expansion strategy. The company's facilities are built to comply with global GMP standards, including those of the FDA and EMA, enabling the production of complex injectables and solid oral dosage forms. Its product portfolio, integrated with its parent company, focuses on therapeutic areas such as diagnostic imaging, anti-infectives, and cardiovascular health. Hainan Zhuoke supports the commercialization of key products like gadobutrol and daptomycin in major global markets.